Nova Patents
IS8719A

Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds.

Abstract

The use of esters of L-carnitine and alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds is described. The esters according to the invention have general formula (II) <CHEM> wherein the R groups are as defined in the description.

Term

1.5 yearsto projected expiry

Projected expiry 7 March 2028, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed and published
  3. Today
  4. Projected expiry

110 members in 35 offices

This recordMember, by publication datePriority claim25 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
RM990220ItalyA
RM990220ItalyA
0000137ItalyW
0000137ItalyW
IT1999RM00220–––
PCTIT0000137–––
RM990220–––
WO2000IT00137–––

Members110

Family members, oldest first
DocumentOfficeKind
ITRM990220A1ItalyA1
CA2370143A1CanadaA1
CA2650202A1CanadaA1
WO0061543A2World Intellectual Property Organization (WIPO)A2
AU4312300AAustraliaA
WO0061543A3World Intellectual Property Organization (WIPO)A3
IT1306129B1ItalyB1
IS6095AIcelandA
NO20014985D0NorwayD0
NO20014985LNorwayL
NO20085413LNorwayL
KR20010113794ARepublic of KoreaA
BR0009765ABrazilA
SK14312001A3SlovakiaA3
CZ20013617A3CzechiaA3
EP1183228A2European Patent Office (EPO)A2
EA200101076A1Eurasian Patent Organization (EAPO)A1
MXPA01010359AMexicoA
TR200102941T2TürkiyeT2
CN1359370AChinaA
IL145765D0IsraelD0
ZA200109291BSouth AfricaB
HU0201446A2HungaryA2
HUP0201446A2HungaryA2
BG105971ABulgariaA
HRP20010740A2CroatiaA2
HK1045145A1Hong Kong, ChinaA1
HU0201446A3HungaryA3
HUP0201446A3HungaryA3
JP2002541238AJapanA
EE200100518AEstoniaA
TR200202358T2TürkiyeT2
PL351112A1PolandA1
EA200300745A1Eurasian Patent Organization (EAPO)A1
NZ515270ANew ZealandA
EA004459B1Eurasian Patent Organization (EAPO)B1
EP1426044A1European Patent Office (EPO)A1
EP1435232A1European Patent Office (EPO)A1
YU70201AYugoslavia, later Serbia and Montenegro (until 2006)A
AU776301B2AustraliaB2
US2004186175A1United States of AmericaA1
US6797281B1United States of AmericaB1
AU2004224958A1AustraliaA1
EP1183228B1European Patent Office (EPO)B1
AT286873TAustriaT
ATE286873T1AustriaT1
DE60017388D1GermanyD1
US2005079209A1United States of AmericaA1
PT1183228EPortugalE
SI1183228T1SloveniaT1
DK1183228T3DenmarkT3
ES2234591T3SpainT3
EA006021B1Eurasian Patent Organization (EAPO)B1
HRP20010740B1CroatiaB1
NZ528874ANew ZealandA
HK1045145BHong Kong, ChinaB
EP1426044B1European Patent Office (EPO)B1
AT317257TAustriaT
ATE317257T1AustriaT1
DE60017388T2GermanyT2
DE60025961D1GermanyD1
SI1426044T1SloveniaT1
DK1426044T3DenmarkT3
PT1426044EPortugalE
CN1263730CChinaC
DE60025961T2GermanyT2
CN1823731AChinaA
ES2258688T3SpainT3
IL175366D0IsraelD0
KR20060113799ARepublic of KoreaA
HK1092732A1Hong Kong, ChinaA1
KR100684378B1Republic of KoreaB1
IL145765AIsraelA
US2007190128A1United States of AmericaA1
AU2004224958B2AustraliaB2
IL185486D0IsraelD0
KR100798499B1Republic of KoreaB1
BG65312B1BulgariaB1
BG109876ABulgariaA
IS8719AThis recordIcelandA
CN100402017CChinaC
BG65501B1BulgariaB1
IS2476BIcelandB
US7585519B2United States of AmericaB2
NO327742B1NorwayB1
IS2539BIcelandB
US7629003B2United States of AmericaB2
PL204418B1PolandB1
SK287253B6SlovakiaB6
MEP24008AMontenegroA
RS20090448ASerbiaA
RS50911BSerbiaB
ME00113BMontenegroB
IL175366AIsraelA
JP2011042657AJapanA
JP4703855B2JapanB2
CA2370143CCanadaC
CZ302628B6CzechiaB6
EE201100028AEstoniaA
EE05514B1EstoniaB1
Showing 100 of 110